World

Pfizer will have data on the efficacy of its vaccine against the new variant of COVID-19 in two weeks

Pfizer company logo (EFE / EPA / OLIVIER HOSLET / ARCHIVE)
Pfizer company logo (EFE / EPA / OLIVIER HOSLET / ARCHIVE)

The German Laboratory BioNTech, ally of Pfizer, expect to have at the latest “in two weeksthe first results of the studies that will determine if the new variant of COVID-19 detected in South Africa is capable of escaping the protection of the vaccinea spokeswoman said.

We have immediately launched studies on variant B.1.1.529“, that “clearly differs from known variants because it has additional mutations in the spike protein“Characteristic of the SARS-Cov-2 virus, the spokeswoman explained to the news agency AFP.

Pfizer and BioNTech prepared several months ago to adjust their vaccine in less than six weeks and deliver the first doses in 100 days.”If a variant was resistant.

FILE PHOTO: A medical worker prepares a dose of the vaccine "Comirnaty" Pfizer-BioNTech COVID-19 at a vaccination center against coronavirus disease (COVID-19) in Madrid, Spain, November 24, 2021. REUTERS / Sergio Perez
FILE PHOTO: A medical worker prepares a dose of the Pfizer-BioNTech COVID-19 “Comirnaty” vaccine at a coronavirus disease (COVID-19) vaccination center in Madrid, Spain, November 24, 2021. REUTERS / Sergio Perez

The discovery of the new variant by South African scientists has unleashed the world alarm, in the middle of the concern that its many mutations could make it even more dangerous than the Delta strain, highly contagious.

Several countries, including the UK, Italy, Germany and Singapore, have taken steps to restrict travel from South Africa and thus avoid the spread of the variant.

However, Pfizer claimed that even if its injection, based on novel mRNA technology, had to be modified, changes could be made quickly.

This Friday, The World Health Organization announced that it will convene a meeting of experts to evaluate the new variant, amid growing global concern.

Tedros Adhanom Ghebreyesus, WHO Director General, at a ceremony in Geneva, Switzerland, October 18, 2021. Fabrice Coffrini / Pool via REUTERS
Tedros Adhanom Ghebreyesus, WHO Director General, at a ceremony in Geneva, Switzerland, October 18, 2021. Fabrice Coffrini / Pool via REUTERS

The objective of the meeting, as announced by the United Nations international health organization, is to determine whether this variant “should be designated as a variant of interest or a variant of concern.” WHO spokesman Christian Lindmeier said the UN agency’s technical advisory group and other experts on the evolution of the virus were consulting with South African researchers.

Until now, almost 100 sequences of the variant, and the first analyzes show that it has “a large number of mutations” They require further study, Lindmeier said.

Dr. Maria Van Kerkhove, a lead epidemiologist at the WHO, pointed out that this new variant is still not widely known, since there are barely “less than 100 complete genomic sequences available”. In any case, he pointed out that “what is known is that this variant has a large number of mutations and the concern is that when you have so many mutations that can have an impact on how the virus behaves ”.

Thus, he has indicated that for the moment it is too early to know the severity of the appearance of this new strain of the virus. “It will take a few weeks to understand what impact this variant has. There is a lot of work going on. It is a variant that is being monitored. We will discuss whether it will become a variant of interest or concern. and, if so, we will give it a Greek name, but it is something to watch out for ”, he explained.

(With information from AFP)

KEEP READING:

Israel confirmed the first case of the new variant of COVID-19 in its territory and prohibited the entry of travelers from seven African countries
The new variant of COVID-19 affects global financial markets
The WHO meets on an emergency basis to analyze the new variant detected in South Africa

Source link

HELEN HERNANDEZ

Helen Hernandez is our best writer. Helen writes about social news and celebrity gossip. She loves watching movies since childhood. Email: Helen@oicanadian.com Phone : +1 281-333-2229

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker